sc 58125 has been researched along with piperidines in 1 studies
Studies (sc 58125) | Trials (sc 58125) | Recent Studies (post-2010) (sc 58125) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
---|---|---|---|---|---|
93 | 0 | 15 | 40,235 | 5,221 | 14,545 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Graham, SH; Rose, ME; Wu Chen, R; Zhang, Y | 1 |
1 other study(ies) available for sc 58125 and piperidines
Article | Year |
---|---|
Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo.
Topics: Animals; Cell Survival; Cells, Cultured; Cyclin D1; Cyclooxygenase 2; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Neurons; Neuroprotective Agents; Nitrobenzenes; Piperidines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2004 |